These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29111229)

  • 1. The Academic-Industrial Complexity: Failure to Launch.
    Levin LA; Behar-Cohen F
    Trends Pharmacol Sci; 2017 Dec; 38(12):1052-1060. PubMed ID: 29111229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique industrial-academic collaboration towards the next generation of schizophrenia therapeutics.
    Macdonald GJ; Lindsley CW
    Curr Top Med Chem; 2014; 14(3):304-12. PubMed ID: 24283972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 4. Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.
    Thomas CJ; McKew JC
    Curr Top Med Chem; 2014; 14(3):291-3. PubMed ID: 24283974
    [No Abstract]   [Full Text] [Related]  

  • 5. The Alcon Research Institute. A model for interaction between the pharmaceutical industry and academic medicine.
    Leibowitz HM
    Arch Ophthalmol; 1993 Aug; 111(8):1039-40. PubMed ID: 8352685
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.
    Bornstein SR; Licinio J
    Nat Med; 2011 Dec; 17(12):1567-9. PubMed ID: 22146467
    [No Abstract]   [Full Text] [Related]  

  • 7. Rethinking 'academic' drug discovery: the Manchester Institute perspective.
    Jordan AM; Waddell ID; Ogilvie DJ
    Drug Discov Today; 2015 May; 20(5):525-35. PubMed ID: 25542353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular drug discovery in the academic setting: building infrastructure, harnessing strengths, and seeking synergies.
    Gardell SJ; Roth GP; Kelly DP
    J Cardiovasc Transl Res; 2010 Oct; 3(5):431-7. PubMed ID: 20625868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 11. Alliance to bolster translation of academic R&D assets.
    Allison M
    Nat Biotechnol; 2013 Apr; 31(4):275. PubMed ID: 23563411
    [No Abstract]   [Full Text] [Related]  

  • 12. Anecdotes from ITMAT: building capacity for translational science.
    FitzGerald GA
    Clin Pharmacol Ther; 2013 Sep; 94(3):291-6. PubMed ID: 23963214
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: Collaboration between industry-based and academic epidemiologists.
    White A; Robinson N; Egger P; Stender M; Davis K; Weil J; Bowlin S
    Int J Epidemiol; 2008 Feb; 37(1):56-7; discussion 65-8. PubMed ID: 18245051
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH encourages translational collaboration with industry.
    Wadman M
    Nat Rev Drug Discov; 2010 Apr; 9(4):255-6. PubMed ID: 20224566
    [No Abstract]   [Full Text] [Related]  

  • 15. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?
    Littman BH; Marincola FM
    J Transl Med; 2011 May; 9():56. PubMed ID: 21569250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key opinion leaders - a critical perspective.
    Scher JU; Schett G
    Nat Rev Rheumatol; 2021 Feb; 17(2):119-124. PubMed ID: 33257869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery. New institute aims to help academics make medicines.
    Service RF
    Science; 2012 Mar; 335(6074):1288-9. PubMed ID: 22422951
    [No Abstract]   [Full Text] [Related]  

  • 20. Externalizing research through adaptive frameworks.
    Vedel JB; Irwin A; Andersen PH
    Nat Rev Drug Discov; 2013 Oct; 12(10):723-4. PubMed ID: 24080683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.